Publicacións (266) Publicacións de JOSÉ LUIS CALLEJAS RUBIO

2024

  1. Autoimmune and Rheumatic Diseases and Sexuality

    Trends in Andrology and Sexual Medicine (Springer Science and Business Media Deutschland GmbH), pp. 291-304

  2. Does stress response axis activation differ between patients with autoimmune disease and healthy people?

    Stress and Health, Vol. 40, Núm. 4

  3. Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review

    Lupus, Vol. 33, Núm. 1, pp. 83-87

  4. Mepolizumab to treat eosinophilic granulomatosis with polyangiitis

    Medicina Clinica

  5. Mesenteric panniculitis simulating early lymphoma recurrence

    Medicina Clinica

  6. Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain

    Hipertensión y riesgo vascular, Vol. 41, Núm. 1, pp. 5-16

  7. Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis

    Nefrologia

  8. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

  9. Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review

    Autoimmunity Reviews

  10. Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4+ T cells in giant cell arteritis

    Journal of Autoimmunity, Vol. 142

2023

  1. Adherence to antimalarials and glucocorticoids treatment and its association with self-reported disease activity in systemic lupus erythematosus patients

    Lupus, Vol. 32, Núm. 1, pp. 74-82

  2. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment

    Reumatologia Clinica

  3. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation

    Biomedicine and Pharmacotherapy, Vol. 168

  4. COVID-19 vaccine literacy in patients with systemic autoimmune diseases

    Current Psychology, Vol. 42, Núm. 16, pp. 13769-13784

  5. Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  6. Cranial multineuritis associated with anti-GM2 ganglioside antibodies after SARS-CoV-2 infection

    Medicina Clinica

  7. External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1605-1611

  8. Fibrosis pulmonar idiopática y determinaciones serológicas de autoinmunidad

    Medicina clinica

  9. Identification of Mechanisms by Which Genetic Susceptibility Loci Influence Systemic Sclerosis Risk Using Functional Genomics in Primary T Cells and Monocytes

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 1007-1020

  10. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 837-847